Well-differentiated thyroid cancer exhibits active radioactive iodide uptake owing to the appropriate expression of iodide-handling genes, including sodium-iodide symporter (NIS), thyroid peroxidase (TPO), and thyroid-stimulating hormone receptor (TSHR). This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.